Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer, Stage IIIb or IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05096663
What this trial is testing

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
SWOG Cancer Research Network 82
Testing effectiveness (Phase 2)Ended earlyNCT00118131
What this trial is testing

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Medicine and Dentistry of New Jersey 49
Testing effectiveness (Phase 2)Study completedNCT00034164
What this trial is testing

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Achieve Life Sciences 52
Early research (Phase 1)Study completedNCT02897375
What this trial is testing

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Who this might be right for
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more
Emory University 71
Large-scale testing (Phase 3)Study completedNCT02066636
What this trial is testing

A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 1,428
Testing effectiveness (Phase 2)Study completedNCT00481078
What this trial is testing

Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)UnknownNCT06143735
What this trial is testing

Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 99
Not applicableStudy completedNCT00997230
What this trial is testing

Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m

Who this might be right for
Newly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca 4,243
Testing effectiveness (Phase 2)Study completedNCT00950365
What this trial is testing

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Bronchioloalveolar CarcinomaLarge Cell Lung CarcinomaLung Adenocarcinoma+3 more
Albert Einstein College of Medicine 79
Testing effectiveness (Phase 2)Ended earlyNCT01935947
What this trial is testing

Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00287989
What this trial is testing

Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 86
Early research (Phase 1)Study completedNCT00503568
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy

Who this might be right for
Lung Cancer
University of Miami 19
Large-scale testing (Phase 3)Ended earlyNCT00473889
What this trial is testing

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)

Who this might be right for
Stage IIIB or IV Non-Small Cell Lung Cancer
Merck Sharp & Dohme LLC 253
Not applicableStudy completedNCT01012401
What this trial is testing

Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

Who this might be right for
Lung Cancer, Stage IIIb or IV
University of Wisconsin, Madison 284
Large-scale testing (Phase 3)Study completedNCT02031744
What this trial is testing

The Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 530
Not applicableStudy completedNCT00823732
What this trial is testing

Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
City of Hope Medical Center 280
Testing effectiveness (Phase 2)Study completedNCT00400829
What this trial is testing

E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT00570401
What this trial is testing

Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00026156
What this trial is testing

S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 125
Testing effectiveness (Phase 2)Study completedNCT01031225
What this trial is testing

The HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Synta Pharmaceuticals Corp. 113
Next Page